Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-010214
Filing Date
2021-10-04
Accepted
2021-10-04 20:06:15
Documents
1
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-53961.html 4  
1 PRIMARY DOCUMENT marketforms-53961.xml 4 4120
  Complete submission text file 0001214659-21-010214.txt   5882
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451 6174982850
Jordan Edward P. (Reporting) CIK: 0001600814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 211304744